(Q37639332)

21 August 2017

Biomarker-based ovarian carcinoma typing: a histologic investigation in the ovarian tumor tissue analysis consortium (English)

1 reference

Aleksandra Gentry-Maharaj

21 August 2017

0 references

1 reference

22

Aleksandra Gentry-Maharaj

0 references

Martin Köbel

Martin Köbel

1

0 references

Usha Menon

Usha Menon

23

0 references

Susan J. Ramus

Susan J Ramus

26

0 references

Julie M. Cunningham

12

Julie M Cunningham

1 reference

21 August 2017

17

Francesmary Modugno

1 reference

21 August 2017

14

Roberta B Ness

1 reference

21 August 2017

9

Daniel W Visscher

1 reference

21 August 2017

15

Kirsten Moysich

1 reference

21 August 2017

5

Linda E Kelemen

1 reference

21 August 2017

21

Simon A Gayther

1 reference

21 August 2017

8

Brooke L Fridley

1 reference

21 August 2017

27

Ellen L Goode

1 reference

21 August 2017

7

Kimberly R Kalli

1 reference

21 August 2017

11

Robert A Vierkant

1 reference

21 August 2017

10

Gary L Keeney

1 reference

21 August 2017

25

David G Huntsman

1 reference

21 August 2017

18

Clareann Bunker

1 reference

21 August 2017

24

C Blake Gilks

1 reference

21 August 2017

6

Leah Prentice

1 reference

21 August 2017

13

Christine Chow

1 reference

21 August 2017

16

Robert Edwards

1 reference

21 August 2017

Steve E Kalloger

2

1 reference

21 August 2017

Sandra Lee

3

1 reference

21 August 2017

Máire A Duggan

4

1 reference

21 August 2017

Eva L Wozniak

19

1 reference

21 August 2017

Elizabeth Benjamin

20

1 reference

21 August 2017

Ovarian Tumor Tissue Analysis consortium

28

1 reference

21 August 2017

23 July 2013

1 reference

Cancer Epidemiology, Biomarkers & Prevention

21 August 2017

1 reference

21 August 2017

22

1 reference

21 August 2017

1677-1686

1 reference

21 August 2017

10

1 reference

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration

21 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3955399

Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3955399

Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, or acetaminophen and risk of ovarian cancer

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3955399

Assessment of hepatocyte growth factor in ovarian cancer mortality

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3955399

Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3955399

Calculator for ovarian carcinoma subtype prediction

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3955399

ARID1A mutations in endometriosis-associated ovarian carcinomas

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3955399

A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3955399

Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3955399

Prognostic relevance of uncommon ovarian histology in women with stage III/IV epithelial ovarian cancer

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3955399

Diagnosis of epithelial ovarian carcinoma prior to neoadjuvant chemotherapy

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3955399

Genetic variation in TYMS in the one-carbon transfer pathway is associated with ovarian carcinoma types in the Ovarian Cancer Association Consortium

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3955399

Diagnosis of ovarian carcinoma cell type is highly reproducible: a transcanadian study

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3955399

The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3955399

HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3955399

Tumor type and substage predict survival in stage I and II ovarian carcinoma: insights and implications.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3955399

A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3955399

Ovarian carcinoma pathology and genetics: recent advances

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3955399

Ovarian carcinoma subtypes are different diseases: implications for biomarker studies

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3955399

Histologic subtypes of ovarian carcinoma: an overview.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3955399

My approach to and thoughts on the typing of ovarian carcinomas

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3955399

Meta-analysis of BRCA1 and BRCA2 penetrance

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3955399

The kappa statistic in reliability studies: use, interpretation, and sample size requirements.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3955399

Specialized pathology review in patients with ovarian cancer: results from a prospective study

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3955399

Ovarian low-grade serous carcinoma: a comprehensive update

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3955399

Mucinous carcinomas of the ovary and colorectum: different organ, same dilemma.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3955399

Clear cell carcinoma of the ovary: a report from the first Ovarian Clear Cell Symposium, June 24th, 2010.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3955399

BRCA, the oviduct, and the space and time continuum of pelvic serous carcinogenesis.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3955399

Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3955399

Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3955399

Recruitment of newly diagnosed ovarian cancer patients proved challenging in a multicentre biobanking study.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3955399

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3955399

Differences in tumor type in low-stage versus high-stage ovarian carcinomas

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3955399

Characterization of the molecular differences between ovarian endometrioid carcinoma and ovarian serous carcinoma

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3955399

Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3955399

Gene Expression Profiles of Serous, Endometrioid, and Clear Cell Subtypes of Ovarian and Endometrial Cancer

1 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23880734

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Letter to the editor regarding 'Roh MH, Lassin Y, Miron A et al. High-grade fimbrial-ovarian carcinomas are unified by p53, PTEN and PAX2 expression'

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23880734

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23880734

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1158/1055-9965.EPI-13-0391

1 reference

21 August 2017

1 reference

21 August 2017

1 reference